1,641
Views
1
CrossRef citations to date
0
Altmetric
LETTERS TO THE EDITOR: CLINICAL ONCOLOGY

Definitive therapy for squamous cell carcinoma of the anus with synchronous metastases – a report from the Danish Anal Cancer Group

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 321-327 | Received 08 Jul 2021, Accepted 25 Oct 2021, Published online: 24 Nov 2021

References

  • Islami F, Ferlay J, Lortet-Tieulent J, et al. International trends in anal cancer incidence rates. Int J Epidemiol. 2017;46(3):924–938.
  • Nelson VM, Benson AB. Epidemiology of anal canal cancer. Surg Oncol Clin N Am. 2017;26(1):9–15.
  • Bartelink H, Roelofsen F, Eschwege F, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for research and treatment of cancer radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol. 1997;15(5):2040–2049.
  • UKCCCR Anal Cancer Working Party. Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet. 1996;348:1049–1054.
  • Rao S, Sclafani F, Eng C, et al. International rare cancers initiative multicenter randomized phase II trial of cisplatin and fluorouracil versus carboplatin and paclitaxel in advanced anal cancer: InterAAct. J Clin Oncol. 2020;38(22):2510–2518.
  • Guren MG, Aagnes B, Nygård M, et al. Rising incidence and improved survival of anal squamous cell carcinoma in Norway, 1987-2016. Clin Colorectal Cancer. 2019;18(1):e96–103–e103.
  • Cummings BJ. Metastatic anal cancer: the search for cure. Onkologie. 2006;29(1-2):5–6.
  • Gutiontov S, Pitroda S, Weichselbaum R. The spectrum of metastasis: an opportunity for cure? Semin Radiat Oncol. 2021;31(3):174–179.
  • Van Cutsem E, Cervantes A, Adam R, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27(8):1386–1422.
  • Boldrini L, Cellini F, Manfrida S, et al. Use of indirect target gating in magnetic resonance-guided liver stereotactic body radiotherapy: case report of an oligometastatic patient. Cureus. 2018;10(3):e2292.
  • Sousa TT, Santos B do N, Belotto M, et al. Successful hepatectomy for metastatic squamous cell carcinoma of the anal canal-a case report. J Gastrointest Oncol. 2016;7(6):E103–6.
  • Sakanaka K, Ishida Y, Mizowaki T. A case report of locally advanced anal cancer with solitary cutaneous nodular metastasis in the ipsilateral labia majora treated with definitive chemoradiotherapy. Case Rep Oncol. 2019;12(3):721–727.
  • Kim SS, Kim GE, Ko AH. A patient with HIV-Associated metastatic anal squamous cell carcinoma receiving multimodality therapy with curative intent: case report and review of the literature. J Gastrointest Cancer. 2017;48(1):94–99.
  • Tokar M, Bobilev D, Zalmanov S, et al. Combined multimodal approach to the treatment of metastatic anal carcinoma: report of a case and review of the literature. Onkologie. 2006;29(1-2):30–32.
  • Dall'Armellina F, Perret A, Smolenschi C, et al. Hepatic arterial infusion of chemotherapy as an option in a multimodal treatment of metastatic squamous cell carcinoma of the anus. Eur J Cancer. 2021;142:147–149.
  • Goldner M, Platoff R, Betances A, et al. Role of metastasectomy for liver metastasis in stage IV anal cancer. Am J Surg. 2021;221(4):832–838.
  • Sclafani F, Hesselberg G, Thompson SR, et al. Multimodality treatment of oligometastatic anal squamous cell carcinoma: a case series and literature review. J Surg Oncol. 2019;119(4):489–496.
  • Evesque L, Benezery K, Follana P, et al. Multimodal therapy of squamous cell carcinoma of the anus with distant metastasis: a single-institution experience. Dis Colon Rectum. 2017;60(8):785–791.
  • Eng C, Chang GJ, You YN, et al. The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canal. Oncotarget. 2014;5(22):11133–11142.
  • Pawlik TM, Gleisner AL, Bauer TW, et al. Liver-directed surgery for metastatic squamous cell carcinoma to the liver: results of a multi-center analysis. Ann Surg Oncol. 2007;14(10):2807–2816.
  • Hodges JC, Das P, Eng C, et al. Intensity-modulated radiation therapy for the treatment of squamous cell anal cancer with Para-aortic nodal involvement. Int J Radiat Oncol Biol Phys. 2009;75(3):791–794.
  • Holliday EB, Lester SC, Harmsen WS, et al. Extended-field chemoradiation therapy for definitive treatment of anal canal squamous cell carcinoma involving the Para-Aortic lymph nodes. Int J Radiat Oncol Biol Phys. 2018;102(1):102–108.
  • Nilsson MP, Nilsson ED, Johnsson A, et al. Patterns of recurrence in anal cancer: a detailed analysis. Radiat Oncol. 2020;15(1):1–10.
  • Sclafani F, Morano F, Cunningham D, et al. Platinum-fluoropyrimidine and paclitaxel-based chemotherapy in the treatment of advanced anal cancer patients. Oncologist. 2017;22(4):402–408.
  • Kim S, François E, André T, et al. Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study. Lancet Oncol. 2018;19(8):1094–1106.
  • Kim S, Meurisse A, Spehner L, et al. Pooled analysis of 115 patients from updated data of Epitopes-HPV01 and Epitopes-HPV02 studies in first-line advanced anal squamous cell carcinoma. Ther Adv Med Oncol. 2020;12:1–11.
  • Glynne-Jones R, Nilsson PJ, Aschele C, ESTRO, et al. Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Radiother Oncol. 2014;111(3):330–339.
  • Oishi S, Kudaka W, Toita T, et al. Prognostic factors and treatment outcome for patients with stage IVB cervical cancer. Anticancer Res. 2016;36(7):3471–3475.
  • Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57–70.
  • Paduch R. The role of lymphangiogenesis and angiogenesis in tumor metastasis. Cell Oncol (Dordr). 2016;39(5):397–410.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.